209 related articles for article (PubMed ID: 27804209)
41. "Minor" hemoglobinopathies: a risk factor for asthma.
Palma-Carlos AG; Palma-Carlos ML; Costa AC
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):177-82. PubMed ID: 15984316
[TBL] [Abstract][Full Text] [Related]
42. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
44. [Epidemiological profile of hemoglobinopathies: a cross-sectional and descriptive index case study].
Dahmani F; Benkirane S; Kouzih J; Woumki A; Mamad H; Masrar A
Pan Afr Med J; 2017; 27():150. PubMed ID: 28904678
[TBL] [Abstract][Full Text] [Related]
45. β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
Hadipour Dehshal M; Tabrizi Namini M; Hantoushzadeh R; Yousefi Darestani S
Hemoglobin; 2019 May; 43(3):166-173. PubMed ID: 31272240
[TBL] [Abstract][Full Text] [Related]
46. How to setup a successful transplant program for hemoglobinopathies in developing countries: The Cure2Children approach.
Faulkner L
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):71-75. PubMed ID: 32201151
[TBL] [Abstract][Full Text] [Related]
47. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.
Lê PQ; Gulbis B; Dedeken L; Dupont S; Vanderfaeillie A; Heijmans C; Huybrechts S; Devalck C; Efira A; Dresse MF; Rozen L; Benghiat FS; Ferster A
Pediatr Blood Cancer; 2015 Nov; 62(11):1956-61. PubMed ID: 26173735
[TBL] [Abstract][Full Text] [Related]
48. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
49. The interactions of alpha-thalassemia with hemoglobinopathies.
Steinberg MH
Hematol Oncol Clin North Am; 1991 Jun; 5(3):453-73. PubMed ID: 1864819
[TBL] [Abstract][Full Text] [Related]
50. [Clinical consequences of alpha-thalassemia in the Basque Country, Spain. Impact of neonatal screening].
Aristizabal A; Merino S; Catediano E; Sasieta M; Aragües P; Navajas A
An Pediatr (Barc); 2015 Aug; 83(2):85-8. PubMed ID: 25483992
[TBL] [Abstract][Full Text] [Related]
51. Prevalence, Incidence, Trend, and Complications of Thalassemia in Iraq.
Kadhim KA; Baldawi KH; Lami FH
Hemoglobin; 2017 May; 41(3):164-168. PubMed ID: 28836463
[TBL] [Abstract][Full Text] [Related]
52. High birth prevalence of sickle cell disease in Northwestern Tanzania.
Ambrose EE; Makani J; Chami N; Masoza T; Kabyemera R; Peck RN; Kamugisha E; Manjurano A; Kayange N; Smart LR
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766840
[TBL] [Abstract][Full Text] [Related]
53. Microcytic hypochromic anemia: should high performance liquid chromatography be used routinely for screening anemic and antenatal patients?
Philip J; Sarkar RS; Kushwaha N
Indian J Pathol Microbiol; 2013; 56(2):109-13. PubMed ID: 24056645
[TBL] [Abstract][Full Text] [Related]
54. Cord blood transplantation in thalassemia.
Issaragrisil S
Blood Cells; 1994; 20(2-3):259-62; discussion 263. PubMed ID: 7749104
[TBL] [Abstract][Full Text] [Related]
55. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
[TBL] [Abstract][Full Text] [Related]
56. Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?
Evangelidis P; Venou TM; Fani B; Vlachaki E; Gavriilaki E;
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003451
[TBL] [Abstract][Full Text] [Related]
57. [Sickle cell disease: registry of the Spanish Society of Pediatric Hematology].
García Arias MB; Cantalejo López MA; Cela de Julián ME; Bravo Clouzet R; Galarón García P; Beléndez Bieler C
An Pediatr (Barc); 2006 Jan; 64(1):78-84. PubMed ID: 16539921
[TBL] [Abstract][Full Text] [Related]
58. Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.
Rodigari F; Brugnera G; Colombatti R
Front Pediatr; 2022; 10():886674. PubMed ID: 36090573
[TBL] [Abstract][Full Text] [Related]
59. Administrative data sets and health services research on hemoglobinopathies: a review of the literature.
Grosse SD; Boulet SL; Amendah DD; Oyeku SO
Am J Prev Med; 2010 Apr; 38(4 Suppl):S557-67. PubMed ID: 20331958
[TBL] [Abstract][Full Text] [Related]
60. Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients.
Baruah MK; Saikia M; Baruah A
Indian J Pathol Microbiol; 2014; 57(2):236-43. PubMed ID: 24943756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
